A new study found that people with type 2 diabetes who stopped GLP-1 treatment had twice the risk of heart attack, stroke or death compared with those who continued treatment.
Reporting from 1 identified publisher for this event.
These publishers contributed reporting to the broader event history. Not every source addresses the specific development described above.
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Page 8 of 22076
Same format. Every time.
Continue reading — sign in or create a free account with
